Cargando…

Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine

Prostate cancer (PC) is the second most common cancer in men and is the fifth leading cause of cancer-related deaths worldwide. Additionally, there is concern for overdiagnosis and overtreatment of PC. Thus, selection of an appropriate candidate for active surveillance as well as more accurate and l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suh, Yoon Seok, Joung, Jae Young, Kim, Sung Han, Seo, Ho Kyung, Chung, Jinsoo, Lee, Kang Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694577/ https://www.ncbi.nlm.nih.gov/pubmed/29230413 http://dx.doi.org/10.1155/2017/7206307

Ejemplares similares

Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer
por: Suh, Yoon Seok, et al.
Publicado: (2018)

Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2019)

Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison
por: Kim, Sung Han, et al.
Publicado: (2017)

Lifestyle Risk Prediction Model for Prostate Cancer in a Korean Population
por: Kim, Sung Han, et al.
Publicado: (2018)

Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review
por: Song, Won Hoon, et al.
Publicado: (2017)

The Quantified Level of Circulating Prostate Stem Cell Antigen mRNA relative to GAPDH Level Is a Clinically Significant Indictor for Predicting Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy
por: Kim, Sung Han, et al.
Publicado: (2015)

Correlation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal Ultrasonography
por: Kim, Sung Han, et al.
Publicado: (2019)

A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2017)

Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients
por: Cho, In-Chang, et al.
Publicado: (2015)

The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
por: Joung, Jae Young, et al.
Publicado: (2015)

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching
por: Kim, Sung Han, et al.
Publicado: (2018)

PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study
por: Kim, Sung Han, et al.
Publicado: (2017)

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens
por: Cho, In-Chang, et al.
Publicado: (2011)

Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study
por: Kim, Sung Han, et al.
Publicado: (2016)

Docetaxel Chemotherapy of Korean Patients with Hormone-refractory Prostate Cancer : Comparative Analysis between 1st-line and 2nd-line Docetaxel
por: Joung, Jae Young, et al.
Publicado: (2008)

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)

Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine
por: Choi, Yoon Young, et al.
Publicado: (2015)

Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation
por: Kim, Sung Han, et al.
Publicado: (2014)

A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia
por: Kim, Sung Han, et al.
Publicado: (2018)

Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis
por: Kim, Sung Han, et al.
Publicado: (2018)

Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
por: Dulaney, Caleb R., et al.
Publicado: (2016)

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019)

Molecular Characterization of Prostate Cancers in the Precision Medicine Era
por: Giunta, Emilio Francesco, et al.
Publicado: (2021)

Circulating tumor cells in colorectal cancer in the era of precision medicine
por: Hu, Mingchao, et al.
Publicado: (2021)

Clear cell papillary renal cell carcinoma: A case report and review of the literature
por: Kim, Sung Han, et al.
Publicado: (2018)

Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy
por: Joung, Jae Young, et al.
Publicado: (2010)

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2015)

Single-Center Analysis of Human Papillomavirus Infection and P16INK4A Expression among Korean Patients with Penile Cancer
por: Kwon, Whi-An, et al.
Publicado: (2019)

Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study
por: Kim, Sung Han, et al.
Publicado: (2020)

Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review
por: Cho, Min Hyun, et al.
Publicado: (2016)

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma
por: Kim, Sung Han, et al.
Publicado: (2017)

Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray
por: Kim, Sung Han, et al.
Publicado: (2020)

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction
por: Kim, Sung Han, et al.
Publicado: (2017)

Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study
por: Joung, Jae Young, et al.
Publicado: (2015)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vqg775khkjgi1kdiia4hpc95o4